Development and validation of a multiplexed drug level assay in support of combination biologics therapy clinical studies
- 13 April 2019
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 171, 204-211
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Fundamentals of Large-Molecule Protein Therapeutic Bioanalysis Using Ligand-Binding AssaysBioanalysis, 2015
- Method Transfer, Partial Validation, and Cross Validation: Recommendations for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization TeamThe AAPS Journal, 2014
- Validation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samplesJournal of Immunological Methods, 2014
- Cancer immunotherapy comes of ageNature, 2011
- Cytokine Multiplex Analysis2009
- Validation and comparison of two multiplex technologies, Luminex® and Mesoscale Discovery, for human cytokine profilingJournal of Immunological Methods, 2009
- Recommendations for the Bioanalytical Method Validation of Ligand-Binding Assays to Support Pharmacokinetic Assessments of MacromoleculesPharmaceutical Research, 2003
- Measurement-Methods Comparisons and Linear Statistical RelationshipTechnometrics, 1999
- Immunoassay of Human Growth Hormone in PlasmaNature, 1963
- IMMUNOASSAY OF BOVINE AND HUMAN PARATHYROID HORMONEProceedings of the National Academy of Sciences, 1963